News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
160,004 Results
Type
Article (8806)
Company Profile (17)
Press Release (151180)
Multimedia
Podcasts (4)
Webinars (8)
Section
Business (41119)
Career Advice (192)
Deals (7506)
Drug Delivery (12)
Drug Development (8312)
Employer Resources (17)
FDA (7107)
Job Trends (3185)
News (68813)
Policy (8287)
Tag
Academia (458)
Accelerated approval (2)
Adcomms (3)
Allergies (34)
Alliances (10231)
ALS (5)
Alzheimer's disease (203)
Antibody-drug conjugate (ADC) (9)
Approvals (7210)
Artificial intelligence (123)
Autoimmune disease (7)
Automation (7)
Bankruptcy (62)
Best Places to Work (2184)
Biosimilars (17)
Biotechnology (13)
Bladder cancer (13)
Brain cancer (12)
Breast cancer (43)
Cancer (427)
Cardiovascular disease (93)
Career advice (180)
Career pathing (4)
CAR-T (15)
Cell therapy (50)
Cervical cancer (11)
Clinical research (7235)
Collaboration (201)
Compensation (48)
Complete response letters (10)
COVID-19 (318)
C-suite (147)
Cystic fibrosis (8)
Data (846)
Decentralized trials (1)
Denatured (1)
Depression (28)
Diabetes (167)
Diagnostics (1534)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (21)
Drug pricing (10)
Drug shortages (3)
Duchenne muscular dystrophy (7)
Earnings (16473)
Editorial (2)
Employer branding (4)
Employer resources (19)
Events (18951)
Executive appointments (199)
FDA (7994)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Funding (271)
Gene editing (4)
Generative AI (5)
Gene therapy (45)
GLP-1 (274)
Government (1194)
Grass and pollen (1)
Guidances (104)
Healthcare (3749)
HIV (8)
Huntington's disease (4)
Immunology and inflammation (15)
Immuno-oncology (3)
Indications (16)
Infectious disease (334)
Inflammatory bowel disease (18)
Influenza (8)
Intellectual property (42)
Interviews (18)
IPO (2745)
IRA (5)
Job creations (1026)
Job search strategy (164)
JPM (4)
Kidney cancer (3)
Labor market (31)
Layoffs (65)
Leadership (3)
Legal (1570)
Liver cancer (20)
Lung cancer (47)
Lymphoma (15)
Machine learning (7)
Management (5)
Manufacturing (117)
MASH (36)
Medical device (11939)
Medtech (11967)
Mergers & acquisitions (4961)
Metabolic disorders (326)
Multiple sclerosis (20)
NASH (6)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (344)
Neurotech (1)
NextGen: Class of 2026 (1376)
Non-profit (412)
Now hiring (11)
Obesity (136)
Opinion (28)
Ovarian cancer (2)
Pain (70)
Pancreatic cancer (40)
Parkinson's disease (43)
Partnered (8)
Patents (94)
Patient recruitment (93)
Peanut (4)
People (12755)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase 1 (1892)
Phase 2 (3001)
Phase 3 (2786)
Pipeline (895)
Policy (22)
Postmarket research (301)
Preclinical (838)
Press Release (4)
Prostate cancer (42)
Psychedelics (3)
Radiopharmaceuticals (66)
Rare diseases (63)
Real estate (1260)
Recruiting (5)
Regulatory (6530)
Reports (11)
Research institute (366)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (1)
RSV (2)
Schizophrenia (6)
Series A (40)
Series B (45)
Service/supplier (1)
Sickle cell disease (5)
Special edition (4)
Spinal muscular atrophy (7)
Sponsored (8)
Startups (1051)
Supply chain (21)
Tariffs (4)
The Weekly (3)
Vaccines (44)
Venture capital (16)
Weight loss (95)
Women's health (17)
Date
Last 7 days (115)
Last 30 days (397)
Last 365 days (4910)
2026 (479)
2025 (5039)
2024 (6606)
2023 (7869)
2022 (13313)
2021 (12543)
2020 (11711)
2019 (10137)
2018 (7801)
2017 (8182)
2016 (8293)
2015 (9452)
2014 (7577)
2013 (6595)
2012 (7369)
2011 (7457)
2010 (6292)
Location
Africa (161)
Alabama (13)
Alaska (1)
Arizona (57)
Arkansas (6)
Asia (9164)
Australia (1489)
California (1769)
Canada (600)
China (128)
Colorado (161)
Connecticut (76)
Delaware (25)
Europe (17916)
Florida (352)
Georgia (99)
Idaho (7)
Illinois (163)
India (9)
Indiana (128)
Iowa (12)
Japan (56)
Kansas (25)
Kentucky (4)
Louisiana (4)
Maine (6)
Maryland (355)
Massachusetts (984)
Michigan (106)
Minnesota (253)
Mississippi (4)
Missouri (23)
Montana (3)
Nebraska (11)
Nevada (27)
New Hampshire (36)
New Jersey (384)
New Mexico (6)
New York (489)
North Carolina (305)
North Dakota (3)
Northern California (777)
Ohio (76)
Oklahoma (4)
Oregon (10)
Pennsylvania (397)
Puerto Rico (6)
Rhode Island (11)
South America (235)
South Carolina (44)
Southern California (714)
Tennessee (38)
Texas (315)
United States (6732)
Utah (66)
Vermont (1)
Virginia (31)
Washington D.C. (12)
Washington State (89)
West Virginia (2)
Wisconsin (24)
160,004 Results for "analog devices".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Update: Checkerspot and Huvepharma Partner to Commercialize Groundbreaking Human Milk Fat Analog
October 7, 2025
·
3 min read
Press Releases
Analog Pharma Canada launches its first product on the Canadian market
September 10, 2025
·
5 min read
Earnings
GSK Says No to GLP-1s, Prioritizes ‘Downstream Effects’ of Obesity
Instead of joining the increasingly crowded GLP-1 arena, GSK will focus its efforts downstream of obesity—a push currently anchored by its Phase III-ready FGF21 analog efimosfermin alfa for liver fibrosis.
February 4, 2026
·
2 min read
·
Tristan Manalac
Genetown
Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform with Analog Devices
EVONETIX LTD, the company developing semiconductor scale technology to improve access to gene synthesis, announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc., a global semiconductor leader.
December 6, 2023
·
2 min read
Press Releases
Roche enters into a definitive merger agreement to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH
September 18, 2025
·
13 min read
Genetown
ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System
Analog Devices, Inc. (Nasdaq: ADI ) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of the Sensinel ™ Cardiopulmonary Management (CPM) System.
March 5, 2024
·
7 min read
Press Releases
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
September 23, 2025
·
6 min read
In partnership with PII
Bridging Formulation and Device: Integrated Supply Chain Strategies for U.S. Pharma Manufacturing
The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development with drug delivery device design—and leveraging a single‐vendor ecosystem—can deliver significant time, cost, and regulatory advantages for US‑focused drug products, according to industry experts.
December 8, 2025
·
5 min read
·
Jennifer Smith-Parker
Mergers & acquisitions
Roche Makes Major MASH Move With $3.5B 89bio Buy
The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in late-stage development for metabolic dysfunction-associated steatohepatitis.
September 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
March 3, 2025
·
6 min read
1 of 16,001
Next
